Regenerative Aesthetics Exosome Products Market
完整報告名稱與涵蓋範圍
Regenerative Aesthetics Exosome Products Market Size, Share & Trends Analysis Report, By Product Type (Topical Exosome Serums and Ampoules, Professional Post-Procedure Exosome Treatments, Exosome Hair Restoration Products, Injectable and Regulated Exosome Therapeutics in Development), By Source (Human Stem Cell-Derived Exosomes, Plant-Derived Exosome-Like Vesicles, Animal and Other Sources), By Application (Skin Rejuvenation and Anti-Ageing, Post-Laser and Microneedling Recovery, Hair Loss and Scalp Health, Scar and Pigmentation Management), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The regenerative aesthetics exosome products market covers topical, professional-use and hair-restoration products formulated with exosomes or extracellular vesicles derived from stem cells, plants or other sources, sold to aesthetic clinics, medical spas and consumers, together with injectable exosome therapeutics in regulated development. Conventional botulinum toxins, dermal fillers and stem cell therapies are excluded. Revenue is dominated by cosmetic and post-procedure products; injectable therapeutic revenue is modelled from regulatory progress rather than assumed, since injectable exosomes lack approval in the United States and Europe.
Demand is driven by the shift of aesthetic medicine toward regenerative and biostimulatory treatments, by energy-based procedures that create a post-treatment window in which exosomes are applied to speed recovery, and by South Korean manufacturers that commercialised stem cell-derived exosome lines at scale and exported the category. Characterisation standards, potency assays and claims substantiation are maturing, while regulators in the United States and Europe have warned against unapproved injectable use, pushing suppliers toward topical formats and toward formal clinical programs.
South Korea, the United States and China are the largest markets, with Europe and the Middle East growing through clinic networks. Competition includes exosome manufacturing specialists, aesthetic-product brands, large cosmetic groups and extracellular vesicle therapeutics companies exploring dermatology.
The InsightAce study includes revenue forecasts in US$ for all product type, source, application and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Regenerative Aesthetics Exosome Products Market Snapshot
Chapter 4. Global Regenerative Aesthetics Exosome Products Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Type:
5.2.1. Topical Exosome Serums and Ampoules
5.2.2. Professional Post-Procedure Exosome Treatments
5.2.3. Exosome Hair Restoration Products
5.2.4. Injectable and Regulated Exosome Therapeutics in Development
Chapter 6. Market Segmentation 2: By Source Estimates & Trend Analysis
6.1. Source & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Source:
6.2.1. Human Stem Cell-Derived Exosomes
6.2.2. Plant-Derived Exosome-Like Vesicles
6.2.3. Animal and Other Sources
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Skin Rejuvenation and Anti-Ageing
7.2.2. Post-Laser and Microneedling Recovery
7.2.3. Hair Loss and Scalp Health
7.2.4. Scar and Pigmentation Management
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Dermatology and Aesthetic Clinics
8.2.2. Medical Spas
8.2.3. Retail and Online Consumers
Chapter 9. Regenerative Aesthetics Exosome Products Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. ExoCoBio Inc.
11.2. Benev Company Inc.
11.3. Kimera Labs, Inc.
11.4. Elevai Labs Inc.
11.5. Exosome Sciences (Aethlon Medical)
11.6. Direct Biologics, LLC
11.7. Prime Bio Inc.
11.8. Cosmax Inc.
11.9. Amorepacific Corporation
11.10. Evox Therapeutics Ltd.
11.11. Codiak BioSciences (Legacy Platforms)
11.12. Rion, Inc.
11.13. Exopharm Limited
11.14. Galderma S.A.
11.15. AbbVie Inc. (Allergan Aesthetics)
圖表清單 List of Tables & Figures
Table 1. Global Regenerative Aesthetics Exosome Products Revenue Forecast by Product Type, 2026-2035 (US$ Mn)
Figure 1. Global Regenerative Aesthetics Exosome Products Market Snapshot, 2026 & 2035
Table 2. Global Regenerative Aesthetics Exosome Products Revenue Forecast by Source, 2026-2035 (US$ Mn)
Figure 2. Global Regenerative Aesthetics Exosome Products Market Share by Source, 2026 & 2035
Table 3. Global Regenerative Aesthetics Exosome Products Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Regulatory Position of Topical Versus Injectable Exosome Products by Region
Table 4. Global Regenerative Aesthetics Exosome Products Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Post-Procedure Exosome Use Across Laser, Microneedling and Injectable Treatments
Table 5. North America Regenerative Aesthetics Exosome Products Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Regenerative Aesthetics Exosome Products Growth Opportunity Analysis
Table 6. Europe Regenerative Aesthetics Exosome Products Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Exosome Characterisation and Potency Standards Adopted by Leading Suppliers
Table 7. Asia Pacific Regenerative Aesthetics Exosome Products Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key Regenerative Aesthetics Exosome Products Market Participants
Table 8. Latin America and Middle East & Africa Regenerative Aesthetics Exosome Products Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們